Search
for
Sort by
Research 91–120 of 1000+
- 411 THE POTENTIAL OF CIRCULATING ENDOTHELIAL CELLS AS PROGNOSTIC BIOMARKERS IN PROSTATE CANCER
- 341 ANDROGENETIC ALOPECIA AT VARIOUS AGES AND PROSTATE CANCER RISK IN AN EQUAL ACCESS MULTIETHNIC CASE CONTROL SERIES OF VETERANS
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- 5α‐Reductase inhibitors and prostatic disease
- Common urologic diseases in older men and their treatment: how they impact fertility
- Prostate cancer update: 2007
- Urological Oncology: Prostate Cancer
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer
- Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase
- Androgenetic alopecia and prostate cancer: findings from an Australian case-control study.
- Management of Advanced Prostate Cancer Undergoing Major Shift
- Clinical Analysis of Parkinson's Disease with Urinary Bladder Dysfunction:A Report of 64 Cases
- S3 SERUM TRIGLYCERIDE CONCENTRATION AND RISK OF PROSTATE CANCER: A PROSPECTIVE MULTICENTER STUDY
- Melatonin Receptors and Their Role in Human Diseases
- The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer
- Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer
- Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study
- Stem cells, organoids and their applications for human diseases: Special issue of BMB Reports in 2023
- Hypoactive Sexual Desire and Other Sexual Dysfunctions Caused by Side Effects of Medicines Used to Treat Various Somatic Diseases and for Contraception
- Six Novel Susceptibility Loci for Early-Onset Androgenetic Alopecia and Their Unexpected Association with Common Diseases
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets
- In vitro and In vivo Effects of 17β-N-(4-phenylcarbamoyl) androst-4-en-3- one Derivatives as 5a-reductase Inhibitors on Androgen-dependent Glands
- Synthesis of novel andostane-N-cyclohexyl-17-carboxamides, and their effect on the 5α-reductase isoform 2, the androgen receptor, and androgen-dependent glands
- Epidemiology and treatment modalities for the management of benign prostatic hyperplasia
- Therapeutic Androgen Receptor Ligands
- The Effect of Anti-Androgens on the Response of Rat Preputial Glands to Testosterone*
- The finasteride riddle
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective